US President Joe Biden yesterday expressed support for a Israel-Gaza ceasefire in a call with Israel’s Prime Minister Netanyahu, and today EU foreign ministers will meet to discuss the conflict, and a biotech company developing medicines that mimic the painkilling effects of cannabis is set to list in London this week. Plus, the FT’s South China correspondent, Primrose Riordan, explains why activists are calling BlackRock “inconsistent” in its ESG commitments. 


Biden backs ceasefire in Israel-Palestinian conflict

https://www.ft.com/content/d388d8b4-94ce-49d1-b8ab-df171286fdad


Europeans hamstrung by rifts on Gaza conflict

https://www.ft.com/content/6c42bcb1-7013-4b74-8526-35ef7fae6f5d?


Start-up focused on painkilling effects of cannabis to list in London

https://www.ft.com/content/2952b9c9-f14a-4300-b1ac-d6c6bf5f8c8f?


BlackRock accused of ESG inconsistency over Indonesia palm oil

https://www.ft.com/content/479b9dd2-c738-4310-8b1e-afdfbd3921b0



See acast.com/privacy for privacy and opt-out information.

Transcripts are not currently available for all podcasts, view our accessibility guide.

Get alerts on FT News Briefing when a new story is published

Copyright The Financial Times Limited 2022. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Comments have not been enabled for this article.

Follow the topics in this podcast